Shankhini: Benefits, Evidence & Safety

TL;DR

Shankhini (Euphorbia dracunculoides) is a classical Ayurvedic purgative drug: Caraka Samhita (Kalpa Sthana 11) devotes a chapter to its fruit-based virechana (therapeutic purgation) formulations. It is not a self-care herb: classical use requires preparation and supervision. Modern research is preclinical only: liver protection in rats and isolated diterpenoids that killed leukemia cells in test tubes.

(56 words. Sources: Saptalashankhini Kalpa Adhyaya, carakasamhitaonline.com, DOI 10.47468/CSNE.2020.e01.s07.012; Batool et al. 2017, BMC Complement Altern Med; Yan et al. 2022, Arabian J Chem.)

What it is

Shankhini is identified in the classical Ayurvedic tradition as Euphorbia dracunculoides Lam., a branched annual herb of the spurge family (Euphorbiaceae) found across the plains and low hills of India (Saptalashankhini Kalpa Adhyaya). Caraka Samhita's Kalpa Sthana, chapter 11 (Saptalashankhini Kalpa Adhyaya), is devoted to pharmaceutical preparations of Saptala and Shankhini for shodhana (purification); Shankhini is classified as phalini: the fruit is the part used (Saptalashankhini Kalpa Adhyaya). A note on identity: the name Shankhini/Shankini has been mapped to different plants in different commentaries, including Canscora decussata in one Ashtanga Hridayam commentary tradition and as a synonym of Shankhpushpi elsewhere, so botanical identity should be verified on any product (same chapter summary; Ashtanga Hridayam Kalpa translation). This article follows the Caraka Samhita identification (E. dracunculoides), the most authoritative classical anchor.

Traditional use

In classical Ayurveda, Shankhini is a virechana drug, it eliminates dosha through therapeutic purgation, and belongs to the shodhana kashaya (purification-medicine group) (Saptalashankhini Kalpa Adhyaya). It is called tiktala for its bitter (tikta) property, considered good for pacifying pitta through purgation, and is described together with Saptala because of their botanical similarity (same source). The chapter describes dozens of formulations of the two drugs for virechana (39 virechana formulations, the rest for vamana), and notes their sharp, spreading qualities (tikshna, vikasi): which is why they are combined with other drugs to moderate adverse effects (same source). Crucially, this is a drug of supervised clinical purification procedures, not a home remedy. These are traditional claims, not clinical proof.

What modern research says

No human clinical trials of Euphorbia dracunculoides were found. The published work is limited to animal and test-tube studies, and none of it validates the traditional purgative use.

Liver protection (animal)

A methanolic extract of the aerial parts (200 and 400 mg/kg, three times a week for four weeks) protected rats against carbon-tetrachloride-induced liver and DNA damage. The investigators noted that earlier work had established in-vitro antioxidant and in-vivo anti-inflammatory activity for the plant (animal study) (Batool, Khan & Majid, BMC Complementary and Alternative Medicine, 2017;17:223). Local Pakistani communities use the plant for rheumatism and edema, per the same paper's background. This is early animal evidence only.

Cytotoxic diterpenoids (test tube)

Four new diterpenoids (euphoranes A–D) plus twelve known compounds were isolated from the whole plant. Euphorane C induced cell-cycle arrest at G0/G1 and apoptosis in human leukemia K562 cells with an IC50 of 3.59 µM (in-vitro study) (Yan et al., Arabian Journal of Chemistry, 2022). Killing leukemia cells in a dish is drug-discovery chemistry, not evidence of anticancer effect in people: and Euphorbia diterpenes include known irritants and tumor promoters in other species, so this cuts both ways.

Cytotoxicity screening (test tube)

A methanolic fruit extract showed cytotoxicity in the brine-shrimp lethality assay and inhibited seed germination and seedling growth in radish and canola: the authors proposed it as a potential bio-herbicide (in-vitro/plant study) (Pak J Bot). This is toxicity screening, not therapeutic evidence, and it underscores that the plant contains biologically aggressive compounds.

Safety & contraindications

No published human safety data, pregnancy data, or drug-interaction studies for Shankhini were found: safety data is limited, so talk to a clinician, and do not self-administer. The classical texts themselves flag this drug as sharp and spreading (tikshna, vikasi), requiring processing and combination with moderating drugs, and restrict it to supervised virechana procedures (Saptalashankhini Kalpa Adhyaya). As a purgative drug it should be avoided in pregnancy, and the Euphorbia genus is known for irritant latex: skin and eye contact with the fresh plant should be avoided. Because the name maps to different species in different traditions, never use a product labeled "shankhini" without verifying its botanical identity.

FAQs

What is shankhini used for in Ayurveda?

Classically, Shankhini is a purgative (virechana) drug used in supervised purification therapy to eliminate dosha through the lower tract, grouped with Saptala in Caraka Samhita's Kalpa Sthana chapter 11 (Saptalashankhini Kalpa Adhyaya). It is a procedure-based medicine prepared and administered by qualified practitioners: not a general wellness herb.

Is shankhini the same as shankhpushpi?

No. Shankhpushpi is the well-known brain-tonic drug identified with Convolvulus pluricaulis (among other species), used for memory, stress and cognition (Alzheimer's Drug Discovery Foundation). Shankhini is a distinct classical drug: in the Caraka tradition, Euphorbia dracunculoides, a purgative. The shared "shankh" (conch) root in the names causes frequent confusion, including "Shankhini" appearing as a vernacular synonym of shankhpushpi in trade.

Can I take shankhini at home?

No. Classical texts treat it as a potent, sharp-acting purgative whose adverse effects must be moderated with companion drugs and correct processing, used only within supervised virechana (Saptalashankhini Kalpa Adhyaya). There is no established safe home dose, and no pharmacopoeial dosage could be verified for this article.

Does shankhini treat cancer?

No. A single laboratory compound from the plant (euphorane C) killed human leukemia cells in a dish, which is early-stage chemistry research, not a treatment (Yan et al., 2022). There are no animal or human studies of anticancer effect, and Euphorbia species contain compounds that can be harmful.

Is shankhini safe in pregnancy?

No safety data exist, and as a classical purgative drug it falls in the category Ayurveda excludes in pregnancy. It should be avoided in pregnancy and breastfeeding. More broadly, no one should self-administer Shankhini given the absence of human safety data (Saptalashankhini Kalpa Adhyaya).

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.